PeerVoice Heart & Lung Audio

PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

http://www.peervoice.com

Eine durchschnittliche Folge dieses Podcasts dauert 17m. Bisher sind 167 Folge(n) erschienen. .

Gesamtlänge aller Episoden: 2 days 11 hours 49 minutes

subscribe
share





"Improving Outcomes in Early-Stage EGFR-Mutant NSCLC: What Pathologists Can Do"


"Improving Outcomes in Early-Stage EGFR-Mutant NSCLC: What Pathologists Can Do"


share







   13m
 
 

Reassessing What’s Possible in Early-Stage EGFR-mutant NSCLC: Insights from the Latest Data


Reassessing What’s Possible in Early-Stage EGFR-mutant NSCLC: Insights from the Latest Data


share







   40m
 
 

Best Practices in Early-Stage EGFR-Mutant NSCLC: What Surgeons Need to Know


Best Practices in Early-Stage EGFR-Mutant NSCLC: What Surgeons Need to Know


share







   29m
 
 

Evolving Treatment Paradigm in Early-Stage EGFR-Mutant NSCLC: A Primer for Medical Oncologists


Evolving Treatment Paradigm in Early-Stage EGFR-Mutant NSCLC: A Primer for Medical Oncologists


share







 2021-05-12  16m
 
 

Best Practices in Early-Stage EGFR-Mutant NSCLC: A Primer for Radiation Oncologists


Best Practices in Early-Stage EGFR-Mutant NSCLC: A Primer for Radiation Oncologists


share







 2021-05-11  18m
 
 

Improving Outcomes in Localised EGFR-Mutant NSCLC: Perspectives for Pulmonologists


Improving Outcomes in Localised EGFR-Mutant NSCLC: Perspectives for Pulmonologists


share







 2021-05-08  26m
 
 

"Setting New Goals for Slowing Progression in Chronic Kidney Disease: What Is Possible With GLP-1 RAs?"


"Setting New Goals for Slowing Progression in Chronic Kidney Disease: What Is Possible With GLP-1 RAs?"


share







 2021-05-04  39m
 
 

Understanding Hypercapnia in Adult Respiratory Distress Syndrome: The Quest for Optimal Patient Outcomes


Understanding Hypercapnia in Adult Respiratory Distress Syndrome: The Quest for Optimal Patient Outcomes


share







 2021-03-13  12m
 
 

GnRH Antagonist vs LHRH Agonist: To Desensitize or To Inhibit, That Is the Question!


GnRH Antagonist vs LHRH Agonist: To Desensitize or To Inhibit, That Is the Question!


share







 2021-02-18  19m
 
 

Stroke Prevention, Type 2 Diabetes, and GLP-1 Receptor Agonists: What Neurologists Need to Know


Stroke Prevention, Type 2 Diabetes, and GLP-1 Receptor Agonists: What Neurologists Need to Know


share







 2021-02-04  44m